Adult cervicofacial nocardiosis in the setting of IL-12/23 blockade

Australas J Dermatol. 2019 Nov;60(4):323-324. doi: 10.1111/ajd.13046. Epub 2019 Apr 4.

Authors

Geoffrey Lee^{1

2

3}, Roselle Robosa¹, Gloria Fong^{2

4}, Frederick J Lee^{3

4}, Patricia Lowe^{2

4}, Angie N Pinto¹

Affiliations

¹ Department of Infectious Diseases, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
² Department of Dermatology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
³ Department of Clinical Immunology and Allergy, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
⁴ The University of Sydney, Sydney, New South Wales, Australia.

PMID: 30945266
DOI: 10.1111/ajd.13046

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Australia
Cellulitis / diagnosis
Cellulitis / drug therapy*
Cellulitis / microbiology*
Emergency Service, Hospital
Follow-Up Studies
Humans
Interleukin-12 / metabolism*
Male
Middle Aged
Nocardia / drug effects
Nocardia / isolation & purification
Nocardia Infections / diagnosis*
Nocardia Infections / drug therapy*
Nose / pathology
Nose / surgery
Psoriasis / diagnosis
Psoriasis / drug therapy
Severity of Illness Index
Tertiary Care Centers
Treatment Outcome
Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage*
Ustekinumab / adverse effects
Ustekinumab / therapeutic use

Substances

Interleukin-12
Trimethoprim, Sulfamethoxazole Drug Combination
Ustekinumab